SKAN Group AG (FRA:7VG) EBIT: €24.0 Mil (TTM As of Dec. 2025)


FRA:7VG SKAN Group AG FRA:7VG
62 GF Score
Price €59.00
GF Value €90.87
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is SKAN Group AG EBIT?

SKAN Group AG FRA:7VG +2.61% 62 EBIT is €24.0 Mil as of Dec. 2025. GuruFocus rates FRA:7VG with a GF Score™ of 62/100 and a GF Value™ of €90.87 (Significantly Undervalued). The stock has 6 warning signs investors should review.

SKAN Group AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was €28.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was €24.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SKAN Group AG's annualized ROC % for the quarter that ended in Dec. 2025 was 16.00%. SKAN Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 29.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. SKAN Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.66%.

SKAN Group AG  (FRA:7VG) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SKAN Group AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=65.018 * ( 1 - 8.75% )/( (347.249 + 394.18)/ 2 )
=59.328925/370.7145
=16.00 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=406.732 - 31.22 - ( 56.437 - max(0, 191.325 - 219.588+56.437))
=347.249

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=515.546 - 51.026 - ( 100.822 - max(0, 225.049 - 295.389+100.822))
=394.18

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

SKAN Group AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=55.93/( ( (179.143 + max(-52.969, 0)) + (200.216 + max(-30.648, 0)) )/ 2 )
=55.93/( ( 179.143 + 200.216 )/ 2 )
=55.93/189.6795
=29.49 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(19.015 + 119.343 + -0.002000000000038) - (31.22 + 0 + 160.105)
=-52.969

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(37.557 + 128.518 + 26.372) - (51.026 + 0 + 172.069)
=-30.648

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

SKAN Group AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=23.978/1440.618
=1.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG EBIT Related Terms

SKAN Group AG EBIT Historical Data

* Premium members only.

The historical data trend for SKAN Group AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SKAN Group AG EBIT Chart

SKAN Group AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial 23.89 26.05 35.15 50.56 23.96

SKAN Group AG Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 19.20 19.88 30.07 -3.99 27.97

FRA:7VG vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, SKAN Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SKAN Group AG EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's EV-to-EBIT falls into.


FRA:7VG
62GF Score
SKAN Group AG FRA:7VG
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SKAN Group AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €24.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €24.0 Mil mean?
SKAN Group AG (FRA:7VG) has a EBIT of €24.0 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on SKAN Group AG.
Is SKAN Group AG's EBIT too high?
SKAN Group AG's current EBIT is €24.0 Mil. Overall, SKAN Group AG has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's EBIT compare to ISRG and BDX?
SKAN Group AG's EBIT of €24.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on SKAN Group AG. SKAN Group AG's current EBIT is €24.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (FRA:7VG) is currently considered Significantly Undervalued. The stock's GF Value™ is €90.87, compared to a current price of €59.00 — trading 35.1% below its estimated fair value. The current EBIT is €24.0 Mil. SKAN Group AG's overall GF Score™ is 62/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For SKAN Group AG (FRA:7VG), the current EBIT is €24.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SKAN Group AG (FRA:7VG) Overvalued in 2026?

Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued. The current stock price of €59.00 is trading 35.1% below its estimated GF Value™ of €90.87. GuruFocus considers SKAN Group AG to be Significantly Undervalued.

Key valuation signals for FRA:7VG:

  • EBIT: €24.0 Mil
  • GF Value™: €90.87 vs. price of €59.00 (35.1% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the FRA:7VG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SKAN Group AG Business Description

Address Kreuzstrasse 5, Allschwil, CHE, 4123
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
62GF Score

Get the complete analysis for FRA:7VG

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€59.00
Price
€90.87
GF Value